Radomír Hrdina

2.5k total citations · 1 hit paper
59 papers, 2.1k citations indexed

About

Radomír Hrdina is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Nutrition and Dietetics. According to data from OpenAlex, Radomír Hrdina has authored 59 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cardiology and Cardiovascular Medicine, 15 papers in Oncology and 13 papers in Nutrition and Dietetics. Recurrent topics in Radomír Hrdina's work include Chemotherapy-induced cardiotoxicity and mitigation (19 papers), Cancer Treatment and Pharmacology (10 papers) and Trace Elements in Health (9 papers). Radomír Hrdina is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (19 papers), Cancer Treatment and Pharmacology (10 papers) and Trace Elements in Health (9 papers). Radomír Hrdina collaborates with scholars based in Czechia, Italy and Canada. Radomír Hrdina's co-authors include Tomáš Šimůnek, Přemysl Mladěnka, Michaela Adamcová, Vladimír Geršl, Tomáš Filipský, Martin Štěrba, Olga Popelová, Libuše Zatloukalová, Kateřina Macáková and Michal Říha and has published in prestigious journals such as Food Chemistry, Free Radical Biology and Medicine and RSC Advances.

In The Last Decade

Radomír Hrdina

58 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron

2009 633 citations Tomáš Šimůnek, Martin Štěrba et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Radomír Hrdina Czechia	20	770	490	370	332	312	59	2.1k
Mohamed M. Sayed‐Ahmed Saudi Arabia	29	275 0.4×	784 1.6×	212 0.6×	80 0.2×	291 0.9×	48	2.3k
Beshay N. Zordoky United States	31	800 1.0×	890 1.8×	370 1.0×	82 0.2×	121 0.4×	61	2.7k
Madhusudana Kuncha India	34	177 0.2×	1.0k 2.1×	271 0.7×	174 0.5×	301 1.0×	73	3.2k
Woo Hyun Park South Korea	30	143 0.2×	1.9k 3.9×	315 0.9×	160 0.5×	300 1.0×	138	3.1k
Kenneth A. Conklin United States	12	156 0.2×	627 1.3×	255 0.7×	122 0.4×	200 0.6×	19	1.5k
Yasuyuki Sadzuka Japan	32	173 0.2×	1.1k 2.3×	459 1.2×	205 0.6×	181 0.6×	133	2.9k
Sankarganesh Arunachalam India	19	454 0.6×	448 0.9×	226 0.6×	57 0.2×	114 0.4×	46	1.4k
Umashanker Navik India	19	355 0.5×	796 1.6×	197 0.5×	76 0.2×	82 0.3×	48	2.0k
César L. Ramírez-Tortosa Spain	23	97 0.1×	801 1.6×	226 0.6×	448 1.3×	488 1.6×	52	2.6k
Xu Han China	27	178 0.2×	971 2.0×	179 0.5×	116 0.3×	101 0.3×	53	2.3k

Countries citing papers authored by Radomír Hrdina

Since Specialization

Citations

This map shows the geographic impact of Radomír Hrdina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Radomír Hrdina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Radomír Hrdina more than expected).

Fields of papers citing papers by Radomír Hrdina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Radomír Hrdina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Radomír Hrdina. The network helps show where Radomír Hrdina may publish in the future.

Co-authorship network of co-authors of Radomír Hrdina

This figure shows the co-authorship network connecting the top 25 collaborators of Radomír Hrdina. A scholar is included among the top collaborators of Radomír Hrdina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Radomír Hrdina. Radomír Hrdina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Karlíčková, Jana, Michal Říha, Tomáš Filipský, et al.. (2015). Antiplatelet Effects of Flavonoids Mediated by Inhibition of Arachidonic Acid Based Pathway. Planta Medica. 82(01/02). 76–83. 28 indexed citations

Říha, Michal, Marie Vopršalová, Veronika Pilařová, et al.. (2014). Oral administration of quercetin is unable to protect against isoproterenol cardiotoxicity. Naunyn-Schmiedeberg s Archives of Pharmacology. 387(9). 823–835. 15 indexed citations

Filipský, Tomáš, Přemysl Mladěnka, Kateřina Macáková, et al.. (2014). Effect of novel 1-phenyl-3-methyl-4-acylpyrazolones on iron chelation and Fenton reaction. Free Radical Biology and Medicine. 75. S29–S30. 2 indexed citations

Říha, Michal, Jana Karlíčková, Tomáš Filipský, et al.. (2014). In vitro copper-chelating properties of flavonoids. Free Radical Biology and Medicine. 75. S46–S46. 17 indexed citations

Filipský, Tomáš, Michal Říha, Radomír Hrdina, Kateřina Vávrová, & Přemysl Mladěnka. (2013). Mathematical calculations of iron complex stoichiometry by direct UV–Vis spectrophotometry. Bioorganic Chemistry. 49. 1–8. 24 indexed citations

Říha, Michal, Jana Karlíčková, Tomáš Filipský, et al.. (2013). Novel method for rapid copper chelation assessment confirmed low affinity of D-penicillamine for copper in comparison with trientine and 8-hydroxyquinolines. Journal of Inorganic Biochemistry. 123. 80–87. 32 indexed citations

Macáková, Kateřina, Přemysl Mladěnka, Tomáš Filipský, et al.. (2012). Iron reduction potentiates hydroxyl radical formation only in flavonols. Food Chemistry. 135(4). 2584–2592. 57 indexed citations

Macáková, Kateřina, Z Řeháková, Přemysl Mladěnka, et al.. (2012). In vitro platelet antiaggregatory properties of 4-methylcoumarins. Biochimie. 94(12). 2681–2686. 22 indexed citations

Filipský, Tomáš, Přemysl Mladěnka, Kateřina Macáková, et al.. (2011). In vitro characteristics of 1-phenyl-3-methyl-4-acylpyrazol-5-ones iron chelators. Biochimie. 94(1). 125–131. 8 indexed citations

10.

Šimůnek, Tomáš, Y Mazurová, Michaela Adamcová, et al.. (2003). Rabbit Model for in Vivo Study of Anthracycline-Induced Heart Failure and for the Evaluation of Protective Agents. European Journal of Heart Failure. 6(4). 377–387. 49 indexed citations

11.

Adamcová, Michaela, Martin Štěrba, Tomáš Šimůnek, et al.. (2003). Cardiac Troponins Following Repeated Administration of an Iron Chelator – Salicylaldehyd Isonicotinoyl Hydrazone (SIH) – in Rabbits. Acta Medica (Hradec Kralove Czech Republic). 46(4). 171–174. 4 indexed citations

12.

Šimůnek, Tomáš, Martin Štěrba, Radomír Hrdina, et al.. (2003). A Study of Potential Toxic Effects After Repeated 10-Week Administration of a New Iron Chelator – Salicylaldehyde Isonicotinoyl Hydrazone (SIH) to Rabbits. Acta Medica (Hradec Kralove Czech Republic). 46(4). 163–170. 18 indexed citations

13.

Adamcová, Michaela, Vladimír Geršl, V. Pelouch, et al.. (2002). Cardiac troponin T following repeated administration of pyridoxal isonicotinoyl hydrazone in rabbits. Physiological Research. 51(5). 443–448. 8 indexed citations

14.

Adamcová, Michaela, et al.. (2001). Evaluation of cardiac effects of the new antineoplastic drug - dimethoxybenfluron - in the rabbit. Physiological Research. 50(5). 491–499. 6 indexed citations

15.

Adamcová, Michaela, et al.. (2000). [Effects of new antineoplastic agents (dimethoxybenflurone and Oracin) on the cardiovascular system and other parameters in the rabbit in vivo].. PubMed. 43(2). 119–38. 1 indexed citations

16.

Bajgar, J, et al.. (1999). Cholinesterases in dexrazoxane-treated daunorubicin cardiomyopathy in rabbits.. PubMed. 18(4). 335–46. 1 indexed citations

17.

Adamcová, Michaela, et al.. (1999). Cardiac troponin T as a marker of myocardial damage caused by antineoplastic drugs in rabbits. Journal of Cancer Research and Clinical Oncology. 125(5). 268–274. 41 indexed citations

18.

Bajgar, J, Radomír Hrdina, J Vávrová, et al.. (1995). Changes of some biochemical and hematological parameters following administration of daunorubicin in rabbits.. PubMed. 38(2). 79–84.

19.

Hrdina, Radomír, et al.. (1991). Changes in the toxicity and therapeutic efficacy of daunorubicin linked with a biodegradable carrier.. PubMed. 38(3). 265–73. 4 indexed citations

20.

Hrdina, Radomír & J Kvĕtina. (1990). Changes in cardiac output, hepatic and renal functions in rats with isoprenaline-induced heart damage.. PubMed. 32(2). 149–56. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact